BSE filing, NSE: VALSONQ. Summary written from the filing by ALFA Finder's alert engine.
Valson Industries Ltd: key numbers
- Share price
- ₹40.75
- Market cap
- ₹31.22 Cr
- Revenue (annual)
- ₹112.1 Cr
- Net profit (annual)
- ₹0.48 Cr
- P/E (TTM)
- 65.2×Sector 49.5×
- Promoter holding
- 67.75%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Valson Industries Ltd
All →Valson Industries Annual General Meeting
Valson Industries Ltd conducted its 42nd Annual General Meeting on September 19, 2026, via video conferencing, covering ordinary and special business items.
Valson Industries Annual General Meeting
Valson Industries Ltd. issued the notice for its 42nd Annual General Meeting scheduled for 19th September, 2026, to be held via video conferencing.
Valson Industries Q1 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY
Valson Industries Ltd reported revenue from operations of ₹28.8 Cr (+1.4% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · +0.0% YoY
Valson Industries Board Meeting Date
Valson Industries Ltd has scheduled a board meeting for August 14, 2026. The board will consider and approve un-audited financial results for the June 2026 quarter.
Valson Industries Credit Rating
Valson Industries received a reaffirmed Crisil rating of 88+ Stable for long term and A4+ Stable for short term. The rating update is disclosed per Regulation 30.
Valson Industries Price Movement Clarification
Valson Industries provided a clarification regarding recent share price movements. The company confirmed it has no undisclosed information impacting its operations or performance.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.